Current Research Interests
Since joining MSKCC, Rachel Jia works closely with Dr. Glenn Heller in collaboration with physicians from Genitourinary Oncology Service to characterize the association between the novel prognostic marker circulating tumor cells with patient survival among metastatic castration-resistant prostate cancer patients. She also works with Dr. Ethan Basch in Health Outcomes to compare the patient self-report and clinician report on adverse symptom events and examine their associations with various end points. Ms. Jia also works with Dr. Li-Xuan Qin to develop a competing-risk nomogram for predicting local recurrence among soft tissue sarcoma patients using a retrospectively identified patient population, and is currently working towards validating the nomogram on an external clinical trial data set. In addition, she was also involved in several expression array data analysis projects to identify the gene profiling in breast cancer and gastric cancer. Ms. Jia recently started a project with Dr. Mithat Gonen to develop methods for evaluating recurrence free survival as a surrogate endpoint for overall survival among late stage colorectal cancer patients.